Suppr超能文献

皮肤致敏的替代方法:危害识别与效力分类:欧洲替代方法评估合作组织/欧洲化学工业理事会低剂量风险倡议组织/欧洲化妆品协会跨部门研讨会报告,赫尔辛基,2015年4月23日至24日

Alternatives for skin sensitisation: Hazard identification and potency categorisation: Report from an EPAA/CEFIC LRI/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015.

作者信息

Basketter David, Ashikaga Takao, Casati Silvia, Hubesch Bruno, Jaworska Joanna, de Knecht Joop, Landsiedel Robert, Manou Irene, Mehling Annette, Petersohn Dirk, Rorije Emiel, Rossi Laura H, Steiling Winfried, Teissier Silvia, Worth Andrew

机构信息

DABMEB Consultancy Ltd, Sharnbrook, MK44 1PR, UK.

Shiseido, Yokohama, Japan.

出版信息

Regul Toxicol Pharmacol. 2015 Nov;73(2):660-6. doi: 10.1016/j.yrtph.2015.10.005. Epub 2015 Oct 9.

Abstract

In the two years since the last workshop report, the environment surrounding the prediction of skin sensitisation hazards has experienced major change. Validated non-animal tests are now OECD Test Guidelines. Accordingly, the recent cross sector workshop focused on how to use in vitro data for regulatory decision-making. After a review of general approaches and six case studies, there was broad consensus that a simple, transparent stepwise process involving non-animal methods was an opportunity waiting to be seized. There was also strong feeling the approach should not be so rigidly defined that assay variations/additional tests are locked out. Neither should it preclude more complex integrated approaches being used for other purposes, e.g. potency estimation. All agreed the ultimate goal is a high level of protection of human health. Thus, experience in the population will be the final arbiter of whether toxicological predictions are fit for purpose. Central to this is the reflection that none of the existing animal assays is perfect; the non-animal methods should not be expected to be so either, but by integrated use of methods and all other relevant information, including clinical feedback, we have the opportunity to continue to improve toxicology whilst avoiding animal use.

摘要

自上次研讨会报告发布后的两年里,皮肤致敏危害预测的环境发生了重大变化。经过验证的非动物测试现已成为经合组织测试指南。因此,最近的跨部门研讨会聚焦于如何将体外数据用于监管决策。在对一般方法和六个案例研究进行回顾之后,与会者达成了广泛共识,即采用涉及非动物方法的简单、透明的逐步流程是一个有待把握的机遇。与会者还强烈认为,该方法的定义不应过于严格,以免排除分析方法的变化/额外测试。它也不应排除为其他目的(例如效力评估)使用更复杂的综合方法。所有人都认同最终目标是高水平地保护人类健康。因此,人群中的经验将是毒理学预测是否适用的最终裁决者。关键在于认识到现有的动物试验都并非完美;非动物方法也不应被期望做到完美,但通过综合使用各种方法以及所有其他相关信息,包括临床反馈,我们有机会在避免使用动物的同时持续改进毒理学。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验